Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation
Journal of Biological Chemistry · 2024-01 · 300 (1) · 105593
DOI: 10.1016/j.jbc.2023.105593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-01. Verfasst von Zhiyi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Digestive Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Institute of Digestive Diseases,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nedd4 Ubiquitin Protein Ligases, Cadherins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xuzhou Institute of Technology, Basic Research Program of Jiangsu Province, Jiangsu Provincial Commission of Health and Family Planning.
Abstract (Originalsprache)
Neural precursor cell expressed developmentally downregulated 4 (NEDD4), an E3 ubiquitin ligase, is commonly upregulated in human hepatocellular carcinoma (HCC) and functions as an oncogenic factor in the progression of HCC, but the molecular mechanism needs be further explored. In this study, we found that NEDD4 could facilitate the proliferation of HCC cells, which was associated with regulating the ERK signaling. Further investigation showed that protocadherin 17 (PCDH17) was a potential substrate of NEDD4, and restoration of PCDH17 could block the facilitation of ERK signaling and HCC cells proliferation induced by NEDD4 overexpression. Whereafter, we confirmed that NEDD4 interacted with PCDH17 and promoted the Lys33-linked polyubiquitination and degradation of it via the proteasome pathway. Finally, NEDD4 protein level was found to be inversely correlated with that of PCDH17 in human HCC tissues. In conclusion, these results suggest that NEDD4 acts as an E3 ubiquitin ligase for PCDH17 ubiquitination and degradation thereby promoting the proliferation of HCC cells through regulating the ERK signaling, which may provide novel evidence for NEDD4 to be a promising therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Digestive Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Gene…
Förderung
- Xuzhou Institute of Technology
- Basic Research Program of Jiangsu Province
- Jiangsu Provincial Commission of Health and Family Planning
Zitieren
APA
Liu, Z., Hu, Q., Hu, B., Cao, K., Xu, T., Hou, T., Cao, T., Wang, R., Shi, H., & Zhang, B. (2024). Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation. Journal of Biological Chemistry, 300(1), 105593. https://doi.org/10.1016/j.jbc.2023.105593
Vancouver
Liu Z, Hu Q, Hu B, Cao K, Xu T, Hou T, et al. Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation. Journal of Biological Chemistry. 2024;300(1):105593. doi:10.1016/j.jbc.2023.105593
BibTeX
@article{Liu2024,
author = {Liu, Zhiyi and Hu, Qinghe and Hu, Bin and Cao, Kuan and Xu, Tao and Hou, Tianqi and Cao, Tong and Wang, Renhao and Shi, Hengliang and Zhang, Bin},
title = {Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {1},
pages = {105593},
doi = {10.1016/j.jbc.2023.105593}
}
EUVIMED